Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Servona
London, Ontario, Canada
- Ownership
- Private
- Employees
- ~16
- Development stage
- Other
01
Overview
Sernova's ongoing Phase 1/2 clinical trial with the Cell Pouch bio-hybrid organ has demonstrated favorable safety and tolerability with no evidence of fibrosis. The bio-hybrid organ combined with transplanted insulin-producing islet clusters showed efficacy in clinical studies in patients with type 1 diabetes.
- Therapeutic areas
- HematologyEndocrinology
- Modalities
- Cell therapyStem cell therapyDevice
- Industry
- Biotech
02
Partnerships
Evotec
Beyond the preview
Go deeper on Servona.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Servona.